Partial nicotinic receptor agonist (smoking cessation)
Cytisinicline
Brand names: Tabex, Cytisine (specials)
Adult dose
Dose: 25-day tapered schedule starting 1.5mg 6× daily, reducing over 25 days
Route: Oral
Frequency: Tapered
Clinical pearls
- NICE NG209 stop smoking interventions: cytisinicline / cytisine recommended option (similar mechanism to varenicline; lower-cost generic alternative)
- Plant-derived alkaloid (broom plant)
- RCT evidence (RAUORA, others) — comparable efficacy to varenicline at lower price
Contraindications
- Pregnancy
- Breastfeeding
- Unstable cardiovascular disease
- Schizophrenia
- Hypersensitivity
Side effects
- Nausea
- Headache
- Sleep disturbance
- Mood change
- Dry mouth
Interactions
- Other smoking-cessation aids
Monitoring
- Smoking status
- Mood
- Adverse events
Reference: BNF; NICE NG209; UKHSA smoking cessation guidance; SmPC; https://bnf.nice.org.uk/drugs/cytisinicline/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Acute Asthma in Adults · BTS/SIGN British Guideline on Asthma 2019; NICE NG80
- Pulmonary Embolism Assessment · NICE NG158; ESC 2019 PE Guidelines
- Acute Exacerbation of COPD (AECOPD) · NICE NG115; GOLD 2024
- Spontaneous Pneumothorax (Adult) · BTS Pleural Disease 2023
- Atypical Pneumonia (Legionella / Mycoplasma / Chlamydophila) · BTS 2023; IDSA
- COPD Exacerbation Management · NICE NG115 / GOLD 2024